Roche to Fold Struggling Diabetes Business Into Diagnostics Unit

Roche Holding AG will fold its stand-alone diabetes business into its broader diagnostics unit after a decade and a half of declining sales.

The Swiss company said Friday it will “define the organizational and structural changes and their potential impact in the coming months.” Employee headcount at Roche overall will remain stable in 2024 compared to this year, the company also said.

Sales at the diabetes business, which makes blood sugar monitoring equipment, have been in a long downward slide since 2007. Roche faced price cuts and lagged competitors in new technologies such as continuous glucose monitoring, in which a ...